Coronary Microvascular Disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Gender unrestricted, aged 18-85 years 2.Meeting the diagnostic criteria for coronary microvascular disease (IMR = 30) 3.Presenting with clinical symptoms (such as chest tightness, suffocation, pain, or palpitations-one or more of these symptoms) 4.Subjects are informed and voluntarily sign the informed consent form
Exclusion criteria
Exclusion criteria: 1.Acute myocardial infarction within the past 3 months 2.History of acute heart failure episode within the past 3 months 3.Ejection fraction < 40% 4.History of lower extremity arterial stent implantation 5.Complicated by severe valvular stenosis or regurgitation 6.Use of traditional Chinese patent medicines such as Compound Danshen Dripping Pills within the past 3 months 7.Complicated by hyperthyroidism 8.Complicated by lower extremity venous thrombosis 9.Presence of cognitive impairment or inability to cooperate with the investgator 10.Complicated by moderate to severe pulmonary hypertension 11.Complicated by hemorrhagic diseases, currently taking oral anticoagulants, or requiring anticoagulant therapy for existing conditions 12.Newly developed lower extremity venous thrombosis within the past month. 13.Exclusion of individuals who are pregnant, breastfeeding, or have an allergic constitution or other similar conditions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Seattle Angina Scale score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement rate of characteristic parameters of magnetocardiography;Left Ventricular Ejection Fraction;Early to Late Diastolic Mitral Inflow Velocity Ratio; Stroke Volume;Systemic Vascular Resistance;Cardiac Output; | — |
Countries
China
Contacts
Dongzhimen Hospital, Beijing University of Chinese Medicine